SOLUDACTONE 100 mg, lyophilizate and solution for parenteral use 5 bottles of 2 ml
Active ingredients: Potassium canrenoate, TROMÉTAMOL
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Lyophilizate and solution for parenteral use5 bottles of 2 mlintraveineuse
Marketing discontinued
Package details
Original BDPM fields are shown in French.
- Official name
- SOLUDACTONE 100 mg, lyophilisat et solution pour usage parentéral
- Pharmaceutical form
- lyophilisat et solution pour usage parentéral
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre - 5 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 4 Jan 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69637743CIP73252245CIP133400932522453Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TROMÉTAMOLlyophilisat | 0,005 g · une ampoule de lyophilisat | SA |
| CANRÉNOATE DE POTASSIUMlyophilisat | 0,100 g · une ampoule de lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.